Valuation: BioNote, Inc.

Market Cap 449B 292M 256M 236M 221M 414M 27.52B 421M 2.83B 1.1B 13.56B 1.1B 1.07B 47.14B P/E 2024
8.69x
P/E 2025 -6.32x
Enterprise Value 113B 73.42M 64.5M 59.42M 55.56M 104M 6.93B 106M 713M 276M 3.42B 276M 270M 11.87B EV / Sales 2024
0.77x
EV / Sales 2025 1.84x
Free-Float
12.55%
Yield 2024
4.25%
Yield 2025 -
1 day-0.22%
1 week-4.10%
Current month-9.20%
1 month-13.28%
3 months-19.13%
6 months-20.86%
Current year-18.83%
1 week 4,285
Extreme 4285
4,620
1 month 4,285
Extreme 4285
5,120
Current year 4,285
Extreme 4285
6,260
1 year 4,285
Extreme 4285
6,320
3 years 3,800
Extreme 3800
6,460
5 years 3,800
Extreme 3800
11,700
10 years 3,800
Extreme 3800
11,700
Manager TitleAgeSince
Chief Executive Officer 58 2020-07-31
Director of Finance/CFO 54 2021-03-31
Corporate Officer/Principal 50 2017-04-30
Director TitleAgeSince
Chairman 65 2023-02-28
Director/Board Member 58 2020-07-31
Director/Board Member 69 2020-12-17
Date Insider Type Main position Quantity % Market Cap.
25-02-04Don

Chairman

10,000,000 9.8058%
25-02-04Free 10,000,000 9.8058%
24-04-13Others 6,729,843 6.5991%
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%-4.10%-12.08%-2.31% 292M
+1.98%+2.79%-19.61%-38.63% 2.87B
+1.47%-8.10%-5.86%-85.02% 1.69B
-0.20%-14.46%-48.26% - 50.96M
Average +0.78%-4.14%-21.45%-41.99% 1.23B
Weighted average by Cap. +1.75%+0.53%-14.72%-52.61%

Financials

2024 2025
Net sales 103B 66.71M 58.6M 53.99M 50.48M 94.68M 6.29B 96.41M 648M 251M 3.1B 251M 245M 10.78B 118B 76.8M 67.46M 62.15M 58.11M 109M 7.25B 111M 746M 289M 3.57B 288M 282M 12.41B
Net income 55.26B 35.87M 31.51M 29.03M 27.14M 50.9M 3.38B 51.84M 348M 135M 1.67B 135M 132M 5.8B -87.5B -56.79M -49.88M -45.96M -42.97M -80.6M -5.36B -82.08M -551M -214M -2.64B -213M -209M -9.18B
Net Debt -401B -261M -229M -211M -197M -370M -24.59B -377M -2.53B -980M -12.12B -979M -957M -42.12B -336B -218M -192M -177M -165M -310M -20.59B -315M -2.12B -821M -10.15B -819M -801M -35.27B
Logo BioNote, Inc.
BioNote Inc is a Korea-based company principally engaged in the bio-contents business. The Company is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The Company is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
Employees
298
Date Price Change Volume
26-06-25 ₩4,440.00 -0.22% 86,058
26-06-24 ₩4,450.00 +1.71% 96,996
26-06-23 ₩4,375.00 -4.68% 63,623
26-06-22 ₩4,590.00 -1.08% 117,198
26-06-19 ₩4,640.00 +0.22% 78,001
  1. Stock Market
  2. Stocks
  3. A377740 Stock